Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,108
Recruiting: 10,888
Ph III recruiting: 1,278
Growth YoY: +12.8%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,158)

clinicaltrialsPublishedShowing 51–100 of 18,424 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07100847	Periprostatic Neurolysis in Prostate Cancer	active not recruiting	Phase 1	21	University of Texas Southwestern Medical CenterOTHER	1	Sep 29, 2026	clinicaltrials
NCT07127874	A Study of PHN-012 in Patients With Advanced Solid Tumors	recruiting	Phase 1	165	Pheon TherapeuticsINDUSTRY	3	Sep 29, 2026	clinicaltrials